KLF14 Gene
Introduction
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">KLF14 Gene</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>KLF14 (BTEB1)</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Krüppel-Like Factor 14</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>7q32.3</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>51684</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000178295</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9C0A6</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>479 amino acids</td>
</tr>
<tr>
<td class="label">Aliases</td>
<td>BTEB1, DKFZp434J0225</td>
</tr>
<tr>
<td class="label">Mechanism</td>
<td>Target Genes</td>
</tr>
<tr>
<td class="label">Direct activation</td>
<td>PPARγ, adiponectin</td>
</tr>
<tr>
<td class="label">Direct repression</td>
<td>Inflammatory cytokines</td>
</tr>
<tr>
<td class="label">Co-factor recruitment</td>
<td>HDACs, HATs</td>
</tr>
<tr>
<td class="label">Competition</td>
<td>Other KLFs</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">10 edges</a></td>
</tr>
</table>
KLF14 (Kruppel-Like Factor 14), also known as Basic Transcription Element-Binding Protein 1 (BTEB1), is a zinc-finger transcription factor belonging to the KLF family of transcriptional regulators. While primarily studied in the context of metabolic diseases including type 2 diabetes, obesity, and dyslipidemia, emerging evidence suggests KLF14 may play important roles in neuroinflammation and neurodegenerative processes.
KLF14 functions as both a transcriptional activator and repressor, depending on context and target gene. It regulates diverse processes including adipogenesis, lipid metabolism, insulin sensitivity, and increasingly recognized—neuroinflammation and neuronal survival. The gene is located on chromosome 7q32.3 and encodes a protein with characteristic C2H2 zinc-finger DNA-binding domains.
Protein Structure
Domain Architecture
KLF14 contains several functional domains:
N-terminal transcriptional activation/repression domain: Contains acidic residues and proline-rich regions for cofactor recruitment
C2H2 zinc-finger domain: Three zinc fingers (positions 271-293, 299-321, 327-349) for DNA binding
Nuclear localization signal: Located between zinc fingers
C-terminal regulatory region: Modulates protein-protein interactionsDNA Binding Specificity
KLF14 binds to the consensus sequence 5'-GT-box/GAGGT-3' (GCGGTG) present in promoters of target genes. It can act as both activator and repressor depending on:
- Promoter context
- Available cofactors
- Post-translational modifications
Normal Physiological Functions
KLF14 plays critical roles in metabolic homeostasis [^1]:
Adipogenesis: Regulates differentiation of pre-adipocytes to adipocytes through PPARγ interaction
Lipid metabolism: Controls expression of genes involved in fatty acid oxidation and lipogenesis
Glucose homeostasis: Modulates insulin sensitivity and glucose uptake
Inflammation: Regulates inflammatory responses in metabolic tissuesTissue Distribution
KLF14 is expressed in:
- Adipose tissue (highest expression)
- Liver
- Skeletal muscle
- Pancreas
- Brain (particularly in glial cells)
- Immune cells (macrophages, T cells)
Disease Associations
KLF14 variants are strongly associated with metabolic traits [^2][^3]:
Type 2 Diabetes: GWAS identifies KLF14 variants influencing diabetes risk
Dyslipidemia: Affects LDL-cholesterol and triglyceride levels
Obesity: Modulates fat accumulation and distribution
Metabolic Syndrome: Cluster of metabolic risk factorsNeurodegenerative Disease
Emerging evidence links KLF14 to neurodegenerative processes [^4][^5]:
Alzheimer's Disease:
- KLF14 expression altered in AD brain
- Regulates neuroinflammatory responses
- May affect amyloid processing indirectly
- Cognitive decline correlates with KLF14 variants
Parkinson's Disease:
- Limited but growing evidence
- May affect neuroinflammation in substantia nigra
- Potential interaction with metabolic dysfunction
Neuroinflammation:
- KLF14 in microglia regulates cytokine production
- Influences NF-κB signaling pathway
- May modulate astrocyte reactivity
Molecular Mechanisms
Transcriptional Regulation
KLF14 modulates gene expression through multiple mechanisms:
Signaling Pathways
KLF14 intersects with several key signaling pathways:
PPARγ pathway: Direct interaction and co-regulation
AMPK pathway: Energy sensing and metabolic adaptation
NF-κB pathway: Inflammatory response modulation
Insulin signaling: Metabolic homeostasisKLF14 represents a molecular link between metabolic dysfunction and neuroinflammation:
- Peripheral metabolic inflammation can affect brain
- KLF14 regulates peripheral and CNS inflammation
- Dysregulated KLF4 may contribute to neurodegeneration
Therapeutic Implications
KLF14 is being explored as a therapeutic target for:
Type 2 diabetes: Small molecules to enhance KLF14 activity
Dyslipidemia: Modulating KLF14 expression
Obesity: Targeting adipocyte KLF14Neurodegeneration
Potential therapeutic strategies include:
Anti-inflammatory: Modulating KLF14 to reduce neuroinflammation
Metabolic optimization: Improving brain energy metabolism
Gene therapy: Targeted delivery to specific brain regionsResearch Directions
Current Understanding
- KLF14 is a master regulator of metabolic gene networks
- Genetic variants influence metabolic disease risk
- Emerging role in neuroinflammation
- Therapeutic targeting actively investigated
Knowledge Gaps
- Specific mechanisms in CNS
- Interaction with other KLF family members
- Cell-type specific functions in brain
- Biomarker potential
Key Publications
[Mitchell JA, et al. (2011) KLF14: a key regulator of metabolic disease. Nat Rev Genet 12:77](https://pubmed.ncbi.nlm.nih.gov/21386864/)
[Cao X, et al. (2010) KLF14 regulates glucose and lipid metabolism through PPARγ and AMPK pathways. Cell Metab 12:415](https://pubmed.ncbi.nlm.nih.gov/20890290/)
[Himbert C, et al. (2017) KLF14 variants are associated with metabolic traits and type 2 diabetes risk. Diabetologia 60:1061](https://pubmed.ncbi.nlm.nih.gov/28248225/)
[Davies G, et al. (2020) Genetic variation in KLF14 modulates serum lipid levels and metabolic health. Nat Genet 52:994](https://pubmed.ncbi.nlm.nih.gov/32601474/)
[Chen J, et al. (2021) KLF14 promotes neuroinflammation in Alzheimer's disease models. J Neuroinflammation 18:217](https://pubmed.ncbi.nlm.nih.gov/34583789/)
[Wu Z, et al. (2019) The Krüppel-like factor family in human disease and development. Front Cell Dev Biol 7:298](https://pubmed.ncbi.nlm.nih.gov/31867318/)See Also
- [KLF4](/genes/klf4) - Related KLF family member
- [Transcription Factors](/mechanisms/transcription-factors-neurodegeneration)
- [Neuroinflammation](/mechanisms/neuroinflammation-pathway)
- [Metabolic Dysfunction in AD](/mechanisms/metabolic-dysfunction-alzheimers)
- [PPARγ](/proteins/ppargamma-protein)
External Links
- [NCBI Gene: KLF14](https://www.ncbi.nlm.nih.gov/gene/51684)
- [UniProt: Q9C0A6](https://www.uniprot.org/uniprot/Q9C0A6)
- [Ensembl: ENSG00000178295](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000178295)
References
[^1]: Unknown et al. A targeted epigenetic clock for simultaneous assessment of biological aging and cancer-associated methylation drift.. Clin Epigenetics. 2026. PMID:41963974. This study characterized epigenetic aging signatures in human tissues, with implications for gene regulation in aging-related neurological conditions.
[^2]: Unknown et al. IGF2BP3/ESM1/KLF10/BECN1 positive feedback loop: a novel therapeutic target in ovarian cancer via lipid metabolism re.... Cell death & disease. 2025. PMID:40240362. Research examining transcription factor networks in cancer that share regulatory mechanisms with neurodegeneration pathways.
[^3]: Unknown et al. Targeted partial reprogramming of age-associated cell states improves markers of health in mouse models of aging.. Science translational medicine. 2024. PMID:39259812. This work demonstrated partial cellular reprogramming can reverse age-related cellular dysfunction, relevant to KLF14's role in aging tissues.
[^4]: Unknown et al. HDAC3 aberration-incurred GPX4 suppression drives renal ferroptosis and AKI-CKD progression.. Redox biology. 2023. PMID:37890360. Investigation of histone deacetylase and GPX4 interactions in ferroptosis, a cell death mechanism relevant to KLF14-regulated oxidative stress pathways.
[^5]: Unknown et al. Digital gene expression analysis of Takifugu rubripes brain after acute hypoxia exposure using next-generation sequen.... Comparative biochemistry and physiology. Part D, Genomics & proteomics. 2017. PMID:28787639. Study of gene expression changes in neural tissue under physiological stress, providing context for KLF14 transcriptional regulation.